Πλοήγηση ανά Θέμα "CYTOPROTECTION"

Αποτελέσματα 1-2 από 2

Concurrent administration of liposomal doxorubicin improves the survival of patients with invasive bladder cancer undergoing hypofractionated accelerated radiotherapy (HypoARC)

Panteliadou, M.; Touloupidis, S.; Giatromanolaki, A.; Pistevou, K.; Kyrgias, G.; Tsoutsou, P.; Kalaitzis, C.; Koukourakis, M. I. (2011)

Cisplatin-based radio-chemotherapy is an effective alternative to cystectomy. The position of cisplatin has been challenged by novel drugs, while altered radiotherapy fractionation is also tested against conventional ...
Dose Escalation of Amifostine for Radioprotection During Pelvic Accelerated Radiotherapy

Koukourakis, M. I.; Kyrgias, G.; Panteliadou, M.; Papadopoulou, A.; Tsiarkatsi, M.; Papachristou, E.; Bebeli, M. (2013)

Objectives: Experimental data suggest a dose-dependent efficacy of amifostine so that the low overall doses used in clinical trials may have masked the full potential of the drug. In this study, we report our experience ...